ASK REDCHAT ANYTHING ABOUT VOR BIOPHARMA INC.
Vor Biopharma Inc. (NASDAQ: VOR)
Listen to this Section
$13.33
-0.3300
(
-2.42% )
386.8K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| VCAR33 (ALLO)DetailsAcute myeloid leukemia |
Phase 1/2 |
| Trem-cel (VOR33) followed by Mylotarg™DetailsAcute myeloid leukemia |
Phase 1/2 |
Market Data
|
| Open |
$13.33 |
| Previous Close |
$13.66 |
| Volume |
386.8K |
| Market Cap |
$740.18M |
| Day Range |
$13.13 - $14.10 |
| 52 Week Range |
$3.63 - $65.80 |
| Shares Outstanding |
54.19M |
| Change % |
-2.42% |
| Net Change |
▼ -0.3300 |
| Insider Ownership |
-0.05% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-686,092.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-08 |
Sale |
-2361.00 |
ANG ROBERT |
| 2024-08-08 |
Sale |
-999.00 |
Attar Eyal C. |
| 2024-08-08 |
Sale |
-876.00 |
Chakraborty Tirtha |
| 2024-08-05 |
Sale |
-2751.00 |
ANG ROBERT |
| 2024-08-05 |
Sale |
-1146.00 |
Attar Eyal C. |
| 2024-08-05 |
Sale |
-985.00 |
Chakraborty Tirtha |
| 2024-06-04 |
Sale |
-14645.00 |
Attar Eyal C. |
| 2024-05-28 |
Sale |
-30000.00 |
Beckman Daniella |
| 2024-05-28 |
Sale |
-30000.00 |
Lubner David Charles |
| 2024-05-28 |
Sale |
-30000.00 |
Namouni Fouad |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Sep 10, 2025 |
| 3 |
Insider transactions |
2 |
Sep 08, 2025 |
| 4 |
Insider transactions |
1 |
Sep 05, 2025 |
| 8-k |
8K-related |
53 |
Sep 02, 2025 |
| 4 |
Insider transactions |
1 |
Aug 29, 2025 |
| 8-k |
8K-related |
12 |
Aug 27, 2025 |
| 8-k |
8K-related |
15 |
Aug 27, 2025 |
| 4 |
Insider transactions |
1 |
Aug 27, 2025 |
| 10-q |
Quarterly Reports |
74 |
Aug 12, 2025 |
| def |
Proxies and info statements |
4 |
Aug 08, 2025 |